Search
for
Sort by
Research 211–240 of 1000+
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- The Role of Janus Kinase Inhibitors in Dermatology
- Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis
- Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus)
- Combined melanocytic nevus presenting with scalp alopecia associated with alopecia areata: Coincidence or causal?
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- 5α-Reductase inhibitors in androgenetic alopecia
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- Clinical use of 5α-reductase inhibitors
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- Fractional CO₂ laser combined with topical compound betamethasone for Vitiligo-Associated Leukotrichia: a retrospective study of 13 patients with limited effectiveness
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- In Search of Predictive Models for Inhibitors of 5-alpha Reductase 2 Based on the Integration of Bioactivity and Molecular Descriptors Data.
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation